Iterum Therapeutics plc (ITRMF) Operating income 2016–2024
Iterum Therapeutics plc (ITRMF) annual operating income history from SEC filings — each fiscal year as reported.
-$18.7MFY2024 · since FY2016: -$13.4M → -$18.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$18.7M | +60.6% |
| FY2023 | -$47.5M | -56.2% |
| FY2022 | -$30.4M | -23.8% |
| FY2021 | -$24.5M | +23.6% |
| FY2020 | -$32.1M | +68.5% |
| FY2019 | -$102.0M | -33.3% |
| FY2018 | -$76.6M | -159.9% |
| FY2017 | -$29.5M | -120.5% |
| FY2016 | -$13.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice